Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports

AtaiBeckley Inc.
Eli Lilly and Company

AtaiBeckley Inc.

ATAI

0.00

Eli Lilly and Company

LLY

0.00

July 15 (Reuters) - Eli Lilly LLY.N is in talks to acquire psychedelic drugmaker AtaiBeckley ATAI.O, and a deal could be announced as soon as this week, Bloomberg News reported on Wednesday, citing people familiar with the matter.

Eli Lilly and AtaiBeckley were not immediately available for comment outside regular business hours.


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.